ES2056995T3 - Anticuerpo monoclonal anti-cpbii. - Google Patents

Anticuerpo monoclonal anti-cpbii.

Info

Publication number
ES2056995T3
ES2056995T3 ES89106201T ES89106201T ES2056995T3 ES 2056995 T3 ES2056995 T3 ES 2056995T3 ES 89106201 T ES89106201 T ES 89106201T ES 89106201 T ES89106201 T ES 89106201T ES 2056995 T3 ES2056995 T3 ES 2056995T3
Authority
ES
Spain
Prior art keywords
cpbii
monoclonal antibody
antibody anti
sorbor
hybridone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89106201T
Other languages
English (en)
Inventor
Takao Nagoya
Yukio Hattori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of ES2056995T3 publication Critical patent/ES2056995T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)

Abstract

LA INVENCION SE REFIERE A UN ANTICUERPO MONOCLONAL ESPECIFICO PARA CPBII, A UN HIBRIDONA QUE LO SEGREGA, A UN PROCESO DE PURIFICACION DEL CPBII QUE COMPRENDE EL EMPLEO DEL ANTICUERPO MONOCLONAL COMO INMUNOADSORBENTE, Y A UN INMUNOENSAYO DEL CPBII, QUE IMPLICA EL USO DEL CITADO ANTICUERPO MONOCLONAL.
ES89106201T 1988-04-08 1989-04-07 Anticuerpo monoclonal anti-cpbii. Expired - Lifetime ES2056995T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63086753A JP2639684B2 (ja) 1988-04-08 1988-04-08 抗ｃｐｂ▲ｉｉ▼モノクローナル抗体

Publications (1)

Publication Number Publication Date
ES2056995T3 true ES2056995T3 (es) 1994-10-16

Family

ID=13895523

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89106201T Expired - Lifetime ES2056995T3 (es) 1988-04-08 1989-04-07 Anticuerpo monoclonal anti-cpbii.

Country Status (6)

Country Link
EP (1) EP0336441B1 (es)
JP (1) JP2639684B2 (es)
KR (1) KR890015752A (es)
CA (1) CA1335355C (es)
DE (1) DE68916088T2 (es)
ES (1) ES2056995T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
EP0336441A2 (en) 1989-10-11
JP2639684B2 (ja) 1997-08-13
EP0336441B1 (en) 1994-06-15
EP0336441A3 (en) 1990-05-16
KR890015752A (ko) 1989-11-25
DE68916088D1 (de) 1994-07-21
CA1335355C (en) 1995-04-25
JPH01257495A (ja) 1989-10-13
DE68916088T2 (de) 1995-01-26

Similar Documents

Publication Publication Date Title
DK103066C (da) Belysningsarmatur, især operationsbelysning.
ES2114876T3 (es) Hidroxialquilacion de fenoles o tiofenoles con carbonatos organicos ciclicos utilizando catalizadores de triorganofosfino.
PT975327E (pt) Uso de antagonistas de 5ht3 para estimular a lavagem intestinal
IT8019147A0 (it) Manicotto di serraggio.
ES513685A0 (es) Un procedimiento para la produccion de granulos que contienen urea como componente principal.
ES2074249T3 (es) Compuesto tetra-n-glicidilo y mezclas reticulables del mismo.
ES2056995T3 (es) Anticuerpo monoclonal anti-cpbii.
ES2100263T3 (es) Nuevas isohirudinas sinteticas con estabilidad mejorada.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
IT8019563A0 (it) Valvola di ritegno.
ES2053942T3 (es) Empleo de aductos de oxido de 1,2-butileno en compuestos organicos h-azidas como lubricantes y lubricantes que contienen estos aductos.
ES513684A0 (es) Un procedimiento para la produccion de granulos, que contienen urea, como componente mayoritario.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
CH402415A (fr) Procédé de régénération de polyamides, à partir de déchets
ES2083428T3 (es) Uso de derivados de isoxazolin-3-ona como antidepresivos.
SE7712786L (sv) 1-acyl-2-imidazolin och forfarande for dess framstellning
ES2104783T3 (es) Procedimiento para la purificacion de estreptolisina o, estreptolisina o intacta obtenible segun este procedimiento y su utilizacion.
NO985111L (no) Eksplosiv formulering
SE406115B (sv) Sammansatt, elastiskt lager
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
NL184020C (nl) Terugslagklep.
ES2097857T3 (es) Canillas recubiertas, un procedimiento para su fabricacion y su uso en el procesamiento de fibras de vidrio.
ATE3485T1 (de) Vorgefertigter, einteilig winkelfoermig gestalteter muffenkoerper.
ES2061445T3 (es) Un procedimiento para la preparacion de una omega-alquil-amino-tetrahidro-6h-1,3-tiazin-6-ona aromatica.
BE609989A (fr) Appareil d'éclairage, maisons de poupées, etc..

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 336441

Country of ref document: ES